α-conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors

被引:49
|
作者
Nicke, A
Samochocki, M
Loughnan, ML
Bansal, PS
Maelicke, A
Lewis, RJ [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia
[2] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany
关键词
alpha 7 nicotinic acetylcholine receptor; intracardiac ganglia; alpha-conotoxin EpI; alpha-conotoxin AuIB; Xenopus laevis oocyte;
D O I
10.1016/S0014-5793(03)01161-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Xenopus laevis oocyte expression system was used to determine the activities of alpha-conotoxins EpI and the ribbon isomer of AuIB, on defined nicotinic acetylcholine receptors (nAChRs). In contrast to previous findings on intracardiac ganglion neurones, alpha-EpI showed no significant activity on oocyte-expressed alpha3beta4 and alpha3beta2 nAChRs but blocked the alpha7 nAChR with an IC50 value of 30 nM. A similar IC50 value (103 nM) was obtained on the alpha7/5HT(3) chimeric receptor stably expressed in mammalian cells. Ribbon AuIB maintained its selectivity on oocyte-expressed alpha3beta4 receptors but unlike in native cells, where it was 10-fold more potent than native alpha-AuIB, had 25-fold lower activity. These results indicate that as yet unidentified factors influence alpha-conotoxin pharmacology at native versus oocyte-expressed nAChRs. (C) 2003 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:219 / 223
页数:5
相关论文
共 34 条
  • [1] α-conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors (vol 554, pg 219, 2003)
    Nicke, A
    Samochocki, M
    Loughnan, ML
    Bansal, PS
    Maelicke, A
    Lewis, RJ
    FEBS LETTERS, 2004, 557 (1-3): : 294 - 294
  • [2] Mutagenesis of -Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors
    Turner, Matthew W.
    Marquart, Leanna A.
    Phillips, Paul D.
    McDougal, Owen M.
    TOXINS, 2019, 11 (02)
  • [3] Pharmacological profiles of recombinant and native insect nicotinic acetylcholine receptors
    Tomizawa, M
    Millar, NS
    Casida, JE
    INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 35 (12) : 1347 - 1355
  • [4] Structure-activity relationships of α-conotoxins targeting neuronal nicotinic acetylcholine receptors
    Millard, EL
    Daly, NL
    Craik, DJ
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (12): : 2320 - 2326
  • [5] Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors
    Groebe, DR
    Gray, WR
    Abramson, SN
    BIOCHEMISTRY, 1997, 36 (21) : 6469 - 6474
  • [6] Activation of recombinant and native α4β2 nicotinic acetylcholine receptors by sazetidine-A
    Zwart, Ruud
    Mogg, Adrian
    Folly, Elizabeth
    Broad, Lisa M.
    Carbone, Anna
    Moroni, Mirko
    Williams, Andrew
    Zhang, Deyi
    Bermudez, Isabel
    Sher, Emanuele
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : SMA48 - SMA48
  • [7] Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype
    Yu, Rilei
    Tae, Han-Shen
    Tabassum, Nargis
    Shi, Juan
    Jiang, Tao
    Adams, David J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (10) : 4628 - 4634
  • [8] Selectivity of Imidacloprid for fruit fly versus rat nicotinic acetylcholine receptors by molecular modeling
    Liu, Gen-Yan
    Ju, Xiu-Lian
    Cheng, Jin
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (05) : 993 - 1002
  • [9] Selectivity of Imidacloprid for fruit fly versus rat nicotinic acetylcholine receptors by molecular modeling
    Gen-Yan Liu
    Xiu-Lian Ju
    Jin Cheng
    Journal of Molecular Modeling, 2010, 16 : 993 - 1002
  • [10] Minor structural changes in nicotinoid insecticides confer differential subtype selectivity for mammalian nicotinic acetylcholine receptors
    Tomizawa, M
    Casida, JE
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (01) : 115 - 122